A study found no evidence that smokers who used e-cigarettes and other electronic nicotine delivery systems (ENDS) in the United States were more likely to quit smoking cigarettes than smokers who do not use these products. The study, looking at 2015-2016 data, found that 90 percent of people who used both ENDS and traditional cigarettes (dual users) were still smoking one year later. The research was conducted by researchers at the School of Public Health at Georgia State University and funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and the U.S. Food and Drug Administration, Center for Tobacco Products.
While eighty-eight percent of people who used both ENDS and traditional cigarettes (dual users) reported that quitting smoking was an “important reason” for using ENDS and forty-six percent reported they tried to “completely quit” smoking during the one-year study, only nine percent reported having quit at follow-up. More than half continued to smoke traditional cigarettes and use ENDS (dual use), and more than 37 percent were still smoking, but discontinued ENDS. The authors did find that users of ENDS were more likely to try to quit smoking than those who did not use ENDS. However, this did not translate to greater success with quitting smoking compared to smokers who did not use ENDS.
The researchers analyzed data from a survey of 858 smokers who participated in a survey in 2015 and were re-contacted one year later. While the authors recommend further research due to the rapidly evolving ENDS markets and regulatory policies, they concluded that absent any meaningful changes in how ENDS are used by adult smokers, ENDS are unlikely to significantly increase quit rates in the U.S. population.
For a copy of the abstract published in PLOS ONE, go to "Are electronic nicotine delivery systems helping cigarette smokers quit? Evidence from a prospective cohort study of U.S. adult smokers, 2015-2016."
NIDA Press Office
About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to firstname.lastname@example.org. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH. . .Turning Discovery Into Health®